-
公开(公告)号：US5968092A
公开(公告)日：1999-10-19
申请号：US083341
申请日：1998-05-22
CPC分类号： A61F2/82 , A61F2/88 , A61L31/041 , A61L31/044 , A61L31/047 , A61L31/148 , A61L31/16 , A61F2/958 , A61F2210/0004 , A61F2210/0023 , A61F2250/0067 , A61F2250/0068 , A61L2300/42 , A61L2300/604 , A61L2300/606 , A61L2300/622 , Y10S623/901
摘要： A method for making a biodegradable stent for insertion into a lumen, the method involves the casting of a film including a matrix of collagen IV and laminin, drying the film, casting a film containing polylactic acid onto the first dried film to form stent material, drying the material formed and forming the biodegradable material into a stent.
摘要翻译： 一种生物可降解支架用于插入内腔的方法，该方法包括将包含胶原IV和层粘连蛋白基质的膜流延，干燥该膜，将含有聚乳酸的膜浇铸到第一干燥膜上以形成支架材料， 将形成的材料干燥并将可生物降解材料形成支架。
-
公开(公告)号：US07806925B2
公开(公告)日：2010-10-05
申请号：US11041027
申请日：2005-01-21
IPC分类号： A61F2/06
CPC分类号： A61F2/82 , A61F2/88 , A61F2/958 , A61F2210/0004 , A61F2210/0023 , A61F2250/0067 , A61F2250/0068 , A61L31/041 , A61L31/044 , A61L31/047 , A61L31/148 , A61L31/16 , A61L2300/42 , A61L2300/604 , A61L2300/606 , A61L2300/622 , Y10S623/901 , C08L67/04
摘要： A stent includes a main body of a generally tubular shape for insertion into a lumen of a vessel of a living being. The tubular main body includes a substantially biodegradable matrix having collagen IV and laminin that enclose voids within the matrix. The tubular main body also includes a biodegradable strengthening material in contact with the matrix to strengthen the matrix. The tubular main body is essentially saturated with drugs.
摘要翻译： 支架包括用于插入活体血管内腔的大体管状形状的主体。 管状主体包括基本上可生物降解的基质，其具有包围基质内的空隙的胶原IV和层粘连蛋白。 管状主体还包括与基质接触以增强基质的可生物降解的强化材料。 管状主体基本上被药物饱和。
-
公开(公告)号：US06869443B2
公开(公告)日：2005-03-22
申请号：US10108904
申请日：2002-03-28
CPC分类号： A61F2/82 , A61F2/88 , A61F2/958 , A61F2210/0004 , A61F2210/0023 , A61F2250/0067 , A61F2250/0068 , A61L31/041 , A61L31/044 , A61L31/047 , A61L31/148 , A61L31/16 , A61L2300/42 , A61L2300/604 , A61L2300/606 , A61L2300/622 , Y10S623/901 , C08L67/04
摘要： A stent includes a main body of a generally tubular shape for insertion into a lumen of a vessel of a living being. The tubular main body includes a substantially biodegradable matrix having collagen IV and laminin that enclose voids within the matrix. The tubular main body also includes a biodegradable strengthening material in contact with the matrix to strengthen the matrix. The tubular main body is essentially saturated with drugs.
摘要翻译： 支架包括用于插入活体血管内腔的大体管状形状的主体。 管状主体包括基本上可生物降解的基质，其具有包围基质内的空隙的胶原IV和层粘连蛋白。 管状主体还包括与基质接触以增强基质的可生物降解的强化材料。 管状主体基本上被药物饱和。
-
公开(公告)号：US06387124B1
公开(公告)日：2002-05-14
申请号：US09420079
申请日：1999-10-18
IPC分类号： A61F206
CPC分类号： A61F2/82 , A61F2/88 , A61F2/958 , A61F2210/0004 , A61F2210/0023 , A61F2250/0067 , A61F2250/0068 , A61L31/041 , A61L31/044 , A61L31/047 , A61L31/148 , A61L31/16 , A61L2300/42 , A61L2300/604 , A61L2300/606 , A61L2300/622 , Y10S623/901 , C08L67/04
摘要： A stent includes a main body of a generally tubular shape for insertion into a lumen of a vessel of a living being. The tubular main body includes a substantially biodegradable matrix having collagen IV and laminin that enclose voids within the matrix. The tubular main body also includes a biodegradable strengthening material in contact with the matrix to strengthen the matrix. The tubular main body is essentially saturated with drugs.
摘要翻译： 支架包括用于插入活体血管内腔的大体管状形状的主体。 管状主体包括基本上可生物降解的基质，其具有包围基质内的空隙的胶原IV和层粘连蛋白。 管状主体还包括与基质接触以增强基质的可生物降解的强化材料。 管状主体基本上被药物饱和。
-
公开(公告)号：US5769883A
公开(公告)日：1998-06-23
申请号：US561374
申请日：1995-11-21
CPC分类号： A61F2/82 , A61F2/88 , A61L31/041 , A61L31/044 , A61L31/047 , A61L31/148 , A61L31/16 , A61F2/958 , A61F2210/0004 , A61F2210/0023 , A61F2250/0067 , A61F2250/0068 , A61L2300/42 , A61L2300/604 , A61L2300/606 , A61L2300/622 , Y10S623/901
摘要： A stent includes a main body of a generally tubular shape for insertion into a lumen of a vessel of a living being. The tubular main body includes a substantially biodegradable matrix having collagen IV and laminin that enclose voids within the matrix. The tubular main body also includes a biodegradable strengthening material in contact with the matrix to strengthen the matrix. The tubular main body is essentially saturated with drugs.
-
公开(公告)号：US5500013A
公开(公告)日：1996-03-19
申请号：US372822
申请日：1995-01-13
CPC分类号： A61F2/82 , A61F2/88 , A61L31/041 , A61L31/044 , A61L31/047 , A61L31/148 , A61L31/16 , A61F2/958 , A61F2210/0004 , A61F2210/0023 , A61F2250/0067 , A61F2250/0068 , A61L2300/42 , A61L2300/604 , A61L2300/606 , A61L2300/622 , Y10S623/901
摘要： A stent includes a main body of a generally tubular shape for insertion into a lumen of a vessel of a living being. The tubular main body includes a substantially biodegradable matrix having collagen IV and laminin that enclose voids within the matrix. The tubular main body also includes a biodegradable strengthening material in contact with the matrix to strengthen the matrix. The tubular main body is essentially saturated with drugs.
-
公开(公告)号：US5464450A
公开(公告)日：1995-11-07
申请号：US215206
申请日：1994-03-21
IPC分类号： A61F2/00 , A61F2/02 , A61F2/82 , A61F2/88 , A61L31/14 , A61L31/16 , A61F2/06 , A61F2/04 , A61M29/02
CPC分类号： A61F2/82 , A61F2/88 , A61L31/148 , A61L31/16 , A61F2/958 , A61F2210/0004 , A61F2210/0023 , A61F2250/0067 , A61L2300/604
摘要： A stent made of biodegradable material includes a drug that is released at a rate controlled by the rate of degradation of the biodegradable material. The stent includes a main body of a generally tubular shape. The main body may further include a plurality of apertures extending therethrough and a slot defined by opposing edges which permits insertion and positioning of the stent.
摘要翻译： 由可生物降解材料制成的支架包括以可生物降解材料的降解速率控制的速率释放的药物。 支架包括大体管状的主体。 主体还可以包括延伸穿过其中的多个孔和由允许插入和定位支架的相对边缘限定的狭槽。
-
公开(公告)号：US20150273117A1
公开(公告)日：2015-10-01
申请号：US14438327
申请日：2013-10-14
申请人： Lixiao WANG , Urotronic, Inc.
发明人： Lixiao Wang
摘要： Embodiments of the present invention provide a method for treatment of nonvascular body lumen strictures such as benign prostatic hyperplasia (BPH), urethral strictures, ureteral strictures, prostate cancer, esophageal strictures, sinus strictures, biliary tract strictures, asthma and chronic obstructive pulmonary disease (COPD). The method involves delivering, preferably via drug coated balloon catheters, of anti-inflammatory and anti-proliferative drugs (rapamycin or paclitaxel and their analogues) and one or more additives.
摘要翻译： 本发明的实施方案提供了一种用于治疗诸如良性前列腺增生（BPH），尿道狭窄，输尿管狭窄，前列腺癌，食管狭窄，窦狭窄，胆道狭窄，哮喘和慢性阻塞性肺病的非血管性体腔狭窄的方法 COPD）。 该方法优选通过药物涂覆的气囊导管递送抗炎和抗增殖药物（雷帕霉素或紫杉醇及其类似物）和一种或多种添加剂。
-
9.发明授权公开(公告)号：US08425459B2
公开(公告)日：2013-04-23
申请号：US12123956
申请日：2008-05-20
申请人： Lixiao Wang
发明人： Lixiao Wang
IPC分类号： A61M25/10 , A61F2/82 , A61K31/337 , A61K31/4433 , A61K51/02
CPC分类号： A61L29/08 , A61B17/320725 , A61B18/24 , A61B18/245 , A61B2018/00327 , A61B2018/00345 , A61B2018/00446 , A61B2018/00488 , A61B2018/00505 , A61F2/07 , A61F2/24 , A61F2/82 , A61K31/337 , A61K31/436 , A61L29/085 , A61L29/16 , A61L29/18 , A61L31/08 , A61L31/10 , A61L31/16 , A61L31/18 , A61L2300/416 , A61L2300/606 , A61L2300/608 , A61L2420/06 , A61L2420/08 , A61L2430/20 , A61M5/007 , A61M25/09 , A61M25/10 , A61M25/1002 , A61M31/005 , A61M37/00 , A61M2025/105 , A61K2300/00
摘要： The invention relates to a coated medical device for rapid delivery of a therapeutic agent to a tissue in seconds to minutes. The medical device has a layer overlying the exterior surface of the medical device. The layer contains a therapeutic agent, a contrast agent, and an additive.
-
公开(公告)号：US08403910B2
公开(公告)日：2013-03-26
申请号：US13042213
申请日：2011-03-07
申请人： Lixiao Wang
发明人： Lixiao Wang
IPC分类号： A61K31/337 , A61K31/4353 , A61K31/59 , A61F2/01 , A61P35/00 , A61P9/00 , A61P7/02 , A61L29/16
CPC分类号： A61L29/16 , A61K31/337 , A61K31/436 , A61K45/06 , A61L29/08 , A61L29/085 , A61L29/18 , A61L31/16 , A61L31/18 , A61L2300/216 , A61L2300/416 , A61L2300/428 , A61L2300/608 , A61L2300/802 , A61L2420/06 , A61L2420/08 , A61M25/10 , A61M2025/105 , A61M2210/1025 , A61K2300/00
摘要： The invention relates to a medical device for delivering a therapeutic agent to a tissue. The medical device has a layer overlying the exterior surface of the medical device. The layer contains a therapeutic agent and an additive. The additive has a hydrophilic part and a hydrophobic part and the therapeutic agent is not enclosed in micelles or encapsulated in particles or controlled release carriers.
-
-
-
-
-
-
-
-
-
搜索结果
183 条记录 (耗时 0.036 秒)
